RemiStart®... Patient Rebate Program for REMICADE®
Eligible patients pay $5 per infusion*
*$20,000 maximum program benefit per calendar year.
Before the calendar year ends, you will receive information and eligibility requirements for continued benefit in the program.
Janssen Biotech, Inc. is not liable for unintended or unauthorized use of the RemiStart® Patient Rebate Program for REMICADE® MasterCard® if it is lost or stolen. This card is issued by MetaBank®, Member FDIC, pursuant to license by MasterCard International Incorporated. MasterCard is a registered trademark of MasterCard International Incorporated. RemiStart® is not a MetaBank product and is not endorsed by them.